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Abstract
Introduction: Hyperandrogenism may be implicated in the pathogenesis of pre-eclampsia. We hypothesised that there may be a differen-
ce between the levels of testosterone in pregnant women complicated with pre-eclampsia and those of matched women without this
complication.
Material and methods: A case-control study conducted in Tehran, Iran between January and June 2006 included 20 women with modera-
te to severe pre-eclampsia and 20 normotensive pregnant women without complications who were matched for age, body mass index and
gravity. Maternal levels of free testosterone was measured in the two groups and compared.
Results: Free testosterone levels were significantly higher in the pre-eclamptic group (mean = 1.97, SD = 0.58, median = 1.90 ng/dL) than
in the control group (mean = 0.58, SD = 0.29, median=0.50 ng/dL) (P < 0.001).
Conclusions: An increase in serum free testosterone concentration may be considered an important risk factor for pre-eclampsia and
might be implicated in the pathogenesis of pre-eclampsia. (Pol J Endocrinol 2008; 59 (5): 390–392)
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Streszczenie
Wstęp: Hiperandrogenizm może mieć wpływ na patogenezę stanu przedrzucawkowego. Autorzy założyli, że istnieją różnice w zakresie
stężeń testosteronu u kobiet w ciąży powikłanej stanem przedrzucawkowym i dobranych odpowiednio ciężarnych kobiet z grupy kontro-
lnej bez tego powikłania.
Materiał i metody: W badaniu kliniczno-kontrolnym przeprowadzonym w Teheranie w okresie od stycznia do czerwca 2006 roku uczest-
niczyło 20 kobiet z umiarkowanym lub ciężkim stanem przedrzucawkowym i 20 ciężarnych kobiet z prawidłowym ciśnieniem tętniczym
bez powikłań, dobranych pod względem wieku, wskaźnika masy ciała i parametrów ciążowych. Stężenie wolnego testosteronu w surowi-
cy ciężarnych kobiet zmierzono i porównano między grupami.
Wyniki: Stężenie wolnego testosteronu w surowicy było istotnie wyższe u kobiet, u których ciąża była powikłana stanem przedrzucaw-
kowym (średnia = 1,97, SD = 0,58, mediana = 1,90 ng/dl) niż w grupie kontrolnej (średnia = 0,58, SD = 0,29, mediana = 0,50 ng/dl)
(P < 0,001).
Wnioski: Zwiększenie stężenia wolnego testosteronu w surowicy kobiet ciężarnych może być ważnym czynnikiem ryzyka stanu prze-
drzucawkowego i odgrywać znaczącą rolę w patogenezie tego powikłania ciąży. (Endokrynol Pol 2008; 59 (5): 390–392)
Słowa kluczowe: testosteron, stan przedrzucawkowy, patogeneza, ciąża
Introduction
Pre-eclampsia and its complications, such as prematu-
rity, intrauterine growth retardation, perinatal asphy-
xia and placental abruption, can lead to high maternal
and fetal morbidity and mortality, so that an estimated
50 000 women per year worldwide die from pre-eclamp-
sia [1]. Owing to its morbid course, it is necessary to
identify those at risk of the illness and take precautions
[2]. The role of androgens in the pathogenesis of pre-
eclampsia has been studied in many human and ani-
mal samples and hyperandrogenism has been conside-
red one of the important risk factors of pre-eclampsia
[3]. Some studies conclude that hyperandrogenism in
pre-eclamptic patients may be implicated in the patho-
genesis of pre-eclampsia [4, 5], while others have fo-
und no difference in concentrations of androgens in the
cord sera of pre-eclamptic and uncomplicated pregnan-
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cies [6, 7]. In addition, some experimental studies have
been published on the association between testostero-
ne concentration and enzymes which are activated in
pre-eclampsia. Steegers et al. considered the effects of
testosterone on the enzyme epoxide hydrolase, which
is associated with pre-eclampsia. They concluded that
a polymorphism in the gene for microsomal epoxide
hydrolase is associated with pre-eclampsia, and that
women with the high activity genotype in exon 3, which
could reflect differences in the metabolic activation of
endogenous or exogenous toxic compounds, may have
an enhanced susceptibility to pre-eclampsia [8]. In the
light of the results of these studies, therefore, we hypo-
thesised that there may be a difference between the levels
of testosterone in pregnant women complicated with pre-
eclampsia and those of matched women without this
complication. To determine whether the changes in se-
rum testosterone were associated with pre-eclampsia, we
studied the concentrations of free testosterone in pre-
eclamptic women with the aim of demonstrating the role
of this factor in the pathogenesis of pre-eclampsia.
Material and methods
A case-control study was made of 20 primigravidae who
were in the third trimester, carrying singleton pregnan-
cies and suffering from moderate to severe pre-eclamp-
sia, and who had been referred to Mofatteh Hospital in
Tehran between January and June 2006. The women
participated after giving their informed consent and the
protocol of the study had been approved by the Rese-
arch Council of Shahid Beheshti University. A further
20 normotensive pregnant women without complica-
tions and matched for age, body mass index and gravity
were randomly selected. None of the women included
in the study had received either antihypertensive medi-
cations or hormone treatment. None of the subjects had
any history of hypertension or other conditions resul-
ting in hormone disorders such as hirsutism or polycy-
stic ovarian syndrome. Pre-eclampsia was defined as
new-onset hypertension after 20 weeks’ gestation such
that systolic blood pressure of ≥ 140 mm Hg, diastolic
pressure of ≥ 90 mm Hg or both were measured on two
occasions ≥ 6 hours apart, with significant proteinuria
(300 mg/24 h). Venous blood samples were collected,
labelled and centrifuged promptly. Serum samples were
stored at –70°C until determination [9]. The level of free
testosterone was determined by means of RIA.
Results were reported as mean ± standard devia-
tion (SD), median for the quantitative variables and
percentages for the categorical variables. The groups
were compared using Student’s t-test or the Mann-
Whitney U test for the continuous variables. This study
was done with the power of 90%. P values of 0.05 or
less were considered statistically significant. All the sta-
tistical analyses were performed using SPSS version 13.0
(SPSS Inc., Chicago, IL, USA) for Windows.
Results
There were no significant differences in maternal age
and body mass index between the two groups. Howe-
ver, both systolic and diastolic blood pressure readings
in the pre-eclamptic group were higher than in the con-
trol group (Table I). In the group with pre-eclampsia,
30% of patients had proteinuria 2+, 45% of them had
proteinuria 3+ and others had proteinuria 4+. Free te-
stosterone levels were significantly higher in the pre-
eclamptic group than in the control group (Table II).
Table II. Serum total testosterone concentration in pre-
eclampsia and control groups
Tabela II. Całkowite stężenie testosteronu w grupie ciężarnych
ze stanem przedrzucawkowym i w grupie kontrolnej
Groups studied Pre-eclamptic Healthy P value
(n = 20) (n = 20)
Mean 1.97 0.58
Median 1.90 0.50
Standard Deviation 0.58 0.29 < 0.001
Maximum 3.60 1.00
Minimum 1.20 0.20
Data are presented as ng/dL
Table I. Identification of patients in case and control groups
Tabela I. Charakterystyka ciężarnych z grupy „przypadków”
i grupy kontrolnej
Characteristics Age BMI SBP DBP
(year) [kg/m2] [mm Hg] [mm Hg]
Pre-eclamptic group: (n = 20)
Mean 23.55 12.61 16.15 9.90
Median 22.00 12.00 16.00 9.00
Standard Deviation 3.30 5.60 1.78 1.65
Healthy group: (n = 20)
Mean 23.85 12.41 11.25 6.95
Median 22.00 12.00 11.00 6.00
Standard Deviation 5.26 5.20 0.55 0.39
P value 0.830 0.907 < 0.001 < 0.001
BMI — body mass index; SBP — systolic blood pressure; DBP —
diastolic blood -pressure
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Discussion
The results of previous studies concerning the role of
androgens in the pathogenesis of pre-eclampsia have
varied. Some studies cited the increase in androgen le-
vels as one of the causes of pre-eclampsia, whereas this
relationship was not revealed in others. In a study by
Acromite et al. total testosterone and free testosterone
levels were significantly higher in patients with pre-ec-
lampsia than in the control group [4]. This result was
also obtained in studies by Gerulewicz-Vannini et al.
and Salamalekis et al. [9, 10]. Zhorzholadze et al. also
found that testosterone levels increased by 51% in com-
parison with those of women with a physiological pre-
gnancy [11]. However, Fiçicioðlu et al. obtained no sta-
tistically significant difference in total and free testoste-
rone content between pre-eclamptic and healthy pre-
gnant groups, in their study no difference was found
in testosterone levels in a severely pre-eclamptic group
and in a mildly pre-eclamptic group [2]. Furthermore,
in the study conducted by Valadan et al. the testostero-
ne levels were not higher in primigravidae with pre-
eclampsia than in normotensive women of similar ge-
stational and maternal ages, body mass index and neo-
natal sex [12].
It seems that different predictors may influence the
relationship between serum testosterone level and the
incidence and severity of pre-eclampsia. Geographical
and social differences may be one of these effective fac-
tors. In a similar study in Iran, but in a different popu-
lation, the results obtained were not comparable to those
of the present study [13]. Gestational age may be ano-
ther effective factor. In the study performed by Carlsen
et al. it was found that testosterone was elevated in ge-
stational weeks 17 and 33 in women who eventually
developed pre-eclampsia. However, at week 33 eleva-
ted levels of testosterone were seen only in women with
male foetuses [3]. Furthermore, in the study by Troisi et
al. androgen levels were, after adjustments for age and
race, significantly associated with a higher average se-
cond trimester systolic blood pressure, although this rise
was not observed for second trimester diastolic pressu-
re or for third trimester blood pressure [14].
However, several mechanisms in the pre-eclampsia
pathogenesis have been studied in relation to the in-
crease in serum testosterone levels. It has been indica-
ted that alterations in the vascular sensitivity of some
endogen hormones, such as angiotensin II, catechola-
mine and vasopressin, and also a decrease in nitric oxi-
de concentration or its absence may have an important
role in the increase in blood pressure observed in pre-
eclampsia [15, 16]. It has also been suggested that inhi-
bin A has a pathophysiological effect on pre-eclampsia
that is probably mediated by stimulation of androgen
production from theca cells of the ovary [4]. The role of
some gene repeats was also investigated. Tanja et al.
found no significant differences in the mean androgen
receptor gene CAG repeat lengths between unrelated
pre-eclamptic women and controls. However, the shor-
test CAG repeat lengths were found only in the pre-
eclamptic women. According to their study result, an
association is possible between the shortest CAG repe-
ats and pre-eclampsia [17].
In view, therefore, of the probable role of androgen
concentration changes in the occurrence of pre-eclamp-
sia as a serious complication of pregnancy, it seems that
anti-androgens may have a potential role in the mana-
gement of pre-eclampsia [10]. However, this subject
should be investigated further in future studies.
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